Skip to main content

Blog

This week in the New England Journal of Medicine, 2 studies reported on the use of mTor inhibitors in Autosomal Dominant Polycystic Kidney Disease (ADPKD). The results were mixed but overall, disappointing. In the first study, investigators used ope...
  1.   Sunday, 27 June 2010
  2.   General nephrology
  3. 2 Comments
In the June 2010 online version of the Lancet Oncology journal, a provocative report of a recently completed meta-analysis suggests that angiotensin receptor blockers might confer a modest but statistically significant increased risk for cancer. The...
  1.   Monday, 21 June 2010
  2.   Hypertension
  3. 0 Comments
I have never been a fan of vitamins. They fall in to a category of interventions with presumed safety and benefit. An important study in the Journal of the American Medical Association shows the opposite; that vitamins can cause harm in patients with...
  1.   Monday, 10 May 2010
  2.   General nephrology
  3. 0 Comments
Many studies have questioned the effectiveness of hydrochlorothiazide (HCTZ) versus chlorthalidone as a diuretic. In fact, most large scale trials that have used HCTZ have been disappointing (e.g. ACCOMPLISH) while those using chlorthalidone have bee...
  1.   Thursday, 06 May 2010
  2.   Hypertension
  3. 0 Comments
ScienceDaily (May 6, 2010) — Two-year results from phase III clinical trials show the experimental immunosuppressive drug belatacept can better preserve kidney function in kidney transplant recipients while preventing graft rejection when compa...
  1.   Thursday, 06 May 2010
  2.   General nephrology
  3. 0 Comments
UKidney Staff doesn't have any blog post yet.
Unable to load tooltip content.
ukidneyisup